Health Professional Radio - Podcast
Lineage Cell Therapeutics - Cell Therapy Programs
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:33
- Mas informaciones
Informações:
Sinopsis
Brian Culley, CEO of Lineage Cell Therapeutics, a clinical-stage biotechnology company, discusses the three cell therapy programs they currently have in clinical trials: OpRegen - a cell replacement therapy for the treatment of advanced dry age-related macular degeneration (dry AMD), OPC1 - a cell replacement therapy for the treatment of acute spinal cord injuries, and VAC2 - an allogeneic cancer immunotherapy for patients with non-small cell lung cancer (NSCLC).
